Myasthenia gravis and Lambert-Eaton syndrome

Research output: Contribution to journalArticle

9 Scopus citations


Myasthenia gravis is a common autoimmune disorder characterized by the presence of pathogenic antibodies directed against the acetylcholine receptor. Patients present with variable degrees and distribution of fluctuating weakness at times life threatening. Clinical manifestations, establishment of diagnosis, the natural history of myasthenia gravis, and therapeutic options are herein reviewed. Far less common is Lambert-Eaton syndrome (the myasthenic syndrome), another autoimmune disorder due to the presence of antibodies directed against the PQ-type voltage-gated calcium channels. Clinical features and treatment options are summarized.

Original languageEnglish (US)
Pages (from-to)57-68
Number of pages12
JournalTherapeutic Apheresis
Issue number1
StatePublished - Mar 23 2002


  • Immunotherapy of neuromuscular disease
  • Lambert-Eaton syndrome
  • Myasthenia gravis
  • Plasma exchange

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Myasthenia gravis and Lambert-Eaton syndrome'. Together they form a unique fingerprint.

  • Cite this